Xiaochun Li

Xiaochun Li

Auto-generated profile, based on publicly available information

Xiaochun Li

Indiana University School of Medicine

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 March 2022 in Journal of Clinical Oncology
Verified
Journal Article
Open access
QSQianqian Song
Qianqian Song
BBBenjamin Bates
Benjamin Bates
YSYu Raymond Shao
Yu Raymond Shao
FHFang-Chi Hsu
Fang-Chi Hsu
FLFeifan Liu
Feifan Liu
UTUmit Topaloglu
Umit Topaloglu
PURPOSE: To provide real-world evidence on risks and outcomes of breakthrough COVID-19 infections in vaccinated patients with cancer using the largest national cohort of COVID-19 cases and controls.METHODS: We used the National COVID Cohort Collaborative (N3C) to identify breakthrough infections between December 1, 2020, and May 31, 2021. We included patients partially or fully vaccinated with mRNA COVID-19 vaccines with no prior SARS-CoV-2 infection record. Risks for breakthrough infection and severe outcomes were analyzed using logistic regression.RESULTS: A total of 6,860 breakthrough cases were identified within the N3C-vaccinated population, among whom 1,460 (21.3%) were patients with cancer. Solid tumors and hematologic malignancies had significantly higher risks for breakthrough infection (odds ratios [ORs] = 1.12, 95% CI, 1.01 to 1.23 and 4.64, 95% CI, 3.98 to 5.38) and severe outcomes (ORs = 1.33, 95% CI, 1.09 to 1.62 and 1.45, 95% CI, 1.08 to 1.95) compared with noncancer patients, adjusting for age, sex, race/ethnicity, smoking status, vaccine type, and vaccination date. Compared with solid tumors, hematologic malignancies were at increased risk for breakthrough infections (adjusted OR ranged from 2.07 for lymphoma to 7.25 for lymphoid leukemia). Breakthrough risk was reduced after the second vaccine dose for all cancers (OR = 0.04; 95% CI, 0.04 to 0.05), and for Moderna's mRNA-1273 compared with Pfizer's BNT162b2 vaccine (OR = 0.66; 95% CI, 0.62 to 0.70), particularly in patients with multiple myeloma (OR = 0.35; 95% CI, 0.15 to 0.72). Medications with major immunosuppressive effects and bone marrow transplantation were strongly associated with breakthrough risk among the vaccinated population.CONCLUSION: Real-world evidence shows that patients with cancer, especially hematologic malignancies, are at higher risk for developing breakthrough infections and severe outcomes. Patients with vaccination were at markedly decreased risk for breakthrough infections. Further work is needed to assess boosters and new SARS-CoV-2 variants.

1 August 2019 in Current Medical Research and Opinion
Verified
Journal Article
Closed access
XLXiaochun Li
Xiaochun Li
SYShengsheng Yu
Shengsheng Yu
ZZZuoyi Zhang
Zuoyi Zhang
LRLarry Radican
Larry Radican
JCJonathan Cummins
Jonathan Cummins
MWMichael Weiner
Michael Weiner
Objective: Hypoglycemia occurs in 20% to 60% of patients with diabetes mellitus. Identifying at-risk patients can facilitate interventions to lower risk. We sought to develop a hypoglycemia prediction model. Methods: In this retrospective cohort study, urban adults prescribed a diabetes drug between 2004 and 2013 were identified. Demographic and clinical data were extracted from an electronic medical record (EMR). Laboratory tests, diagnostic codes, and natural language processing (NLP) identified hypoglycemia. We compared multiple logistic regression, classification and regression trees (CART), and Random Forest. Models were evaluated on an independent test set or through cross-validation. Results: 38,780 patients had mean age 57 years; 56% were female, 40% African-American, and 39% uninsured. Hypoglycemia occurred in 8,128 (539 identified only by NLP). In logistic regression, factors positively associated with hypoglycemia included infection, non-long-acting insulin, dementia, and recent hypoglycemia. Negatively associated factors included long-acting insulin plus sulfonylurea, and age 75 or older. Models' area under curve was similar (logistic regression, 89%; CART, 88%; Random Forest, 90%, with 10-fold cross-validation). Conclusions: NLP improved identification of hypoglycemia. Non-long-acting insulin was an important risk factor. Decreased risk with age may reflect treatment or diminished awareness of HG. More complex models did not improve prediction.

5 July 2022 in Kidney360
Verified
Journal Article
Closed access
PDF file
AHArvin Halim
Arvin Halim
HBHeather N. Burney
Heather N. Burney
XLXiaochun Li
Xiaochun Li
YLYang Li
Yang Li
CTClaudia Tomkins
Claudia Tomkins
KLKenneth Lim
Kenneth Lim
Key Points: The highest fibroblast growth factor 23 (FGF23) quartile had impaired VO2Max and ventilatory exercise response patterns compared with the lowest FGF23 quartile. FGF23 was associated with changes in VO2Max in advanced CKD and after restitution of the failing kidney by transplantation. FGF23 was only associated with the progression of left ventricular mass index in patients with advanced CKD, however this association was lost after adjustment for dialysis status in the final model and was not associated after kidney transplantation in all models. Background: Fibroblast growth factor 23 (FGF23) is a bone-derived phosphatonin that is elevated in chronic kidney disease (CKD) and has been implicated in the development of cardiovascular disease. It is unknown whether elevated FGF23 in CKD is associated with impaired cardiovascular functional capacity, as assessed by maximum exercise oxygen consumption (VO2Max). We sought to determine whether FGF23 is associated with cardiovascular functional capacity in patients with advanced CKD and after improvement of VO2Max by kidney transplantation. Methods: We performed secondary analysis of 235 patients from the Cardiopulmonary Exercise Testing in Renal Failure and After Kidney Transplantation (CAPER) cohort, which recruited patients with stage 5 CKD who underwent kidney transplantation or were waitlisted and hypertensive controls. All patients underwent cardiopulmonary exercise testing (CPET) and echocardiography and were followed longitudinally for 1 year after study enrollment. Results: Patients across FGF23 quartiles differed in BMI (P=0.004) and mean arterial pressure (P<0.001) but did not significantly differ in sex (P=0.5) or age (P=0.08) compared with patients with lower levels of FGF23. Patients with higher FGF23 levels had impaired VO2Max (Q1: 24.2±4.8 ml/min per kilogram; Q4: 18.6±5.2 ml/min per kilogram; P<0.001), greater left ventricular mass index (LVMI; P<0.001), reduced HR at peak exercise (P<0.001), and maximal workload (P<0.001). Kidney transplantation conferred a significant decline in FGF23 at 2 months (P<0.001) before improvement in VO2Max at 1 year (P=0.008). Multivariable regression modeling revealed that changes in FGF23 was significantly associated with VO2Max in advanced CKD (P<0.001) and after improvement after kidney transplantation (P=0.006). FGF23 was associated with LVMI before kidney transplantation (P=0.003), however this association was lost after adjustment for dialysis status (P=0.4). FGF23 was not associated with LVMI after kidney transplantation in all models. Conclusions: FGF23 levels are associated with alterations in cardiovascular functional capacity in advanced CKD and after kidney transplantation. FGF23 is only associated with structural cardiac adaptations in advanced CKD but this was modified by dialysis status, and was not associated after kidney transplantation.

28 October 2022 in Journal of the American Medical Informatics Association
Verified
Journal Article
Open access
PDF file
AGAgrayan K Gupta
Agrayan K Gupta
SKSuranga N Kasthurirathne
Suranga N Kasthurirathne
HXHuiping Xu
Huiping Xu
XLXiaochun Li
Xiaochun Li
MRMatthew M Ruppert
Matthew M Ruppert
SGShaun J Grannis
Shaun J Grannis
Healthcare systems are hampered by incomplete and fragmented patient health records. Record linkage is widely accepted as a solution to improve the quality and completeness of patient records. However, there does not exist a systematic approach for manually reviewing patient records to create gold standard record linkage data sets. We propose a robust framework for creating and evaluating manually reviewed gold standard data sets for measuring the performance of patient matching algorithms. Our 8-point approach covers data preprocessing, blocking, record adjudication, linkage evaluation, and reviewer characteristics. This framework can help record linkage method developers provide necessary transparency when creating and validating gold standard reference matching data sets. In turn, this transparency will support both the internal and external validity of recording linkage studies and improve the robustness of new record linkage strategies.

29 September 2022 in Journal of Medical Internet Research
Verified
Journal Article
Open access
XLXiaochun Li
Xiaochun Li
HXHuiping Xu
Huiping Xu
SGShaun Grannis
Shaun Grannis
Background: Quality patient care requires comprehensive health care data from a broad set of sources. However, missing data in medical records and matching field selection are 2 real-world challenges in patient-record linkage. Objective: In this study, we aimed to evaluate the extent to which incorporating the missing at random (MAR)–assumption in the Fellegi-Sunter model and using data-driven selected fields improve patient-matching accuracy using real-world use cases. Methods: We adapted the Fellegi-Sunter model to accommodate missing data using the MAR assumption and compared the adaptation to the common strategy of treating missing values as disagreement with matching fields specified by experts or selected by data-driven methods. We used 4 use cases, each containing a random sample of record pairs with match statuses ascertained by manual reviews. Use cases included health information exchange (HIE) record deduplication, linkage of public health registry records to HIE, linkage of Social Security Death Master File records to HIE, and deduplication of newborn screening records, which represent real-world clinical and public health scenarios. Matching performance was evaluated using the sensitivity, specificity, positive predictive value, negative predictive value, and F1-score. Results: Incorporating the MAR assumption in the Fellegi-Sunter model maintained or improved F1-scores, regardless of whether matching fields were expert-specified or selected by data-driven methods. Combining the MAR assumption and data-driven fields optimized the F1-scores in the 4 use cases. Conclusions: MAR is a reasonable assumption in real-world record linkage applications: it maintains or improves F1-scores regardless of whether matching fields are expert-specified or data-driven. Data-driven selection of fields coupled with MAR achieves the best overall performance, which can be especially useful in privacy-preserving record linkage.

14 October 2024 in Clinical Journal of the American Society of Nephrology
Verified
Journal Article
Open access
KLKenneth Lim
Kenneth Lim
MNMatthew Nayor
Matthew Nayor
EAEliott Arroyo
Eliott Arroyo
HBHeather N. Burney
Heather N. Burney
XLXiaochun Li
Xiaochun Li
GLGregory D. Lewis
Gregory D. Lewis
Key Points: Mild-to-moderate CKD is associated with impairment in cardiovascular functional capacity as assessed by oxygen uptake at peak exercise (VO 2 Peak). Cardiac output is significantly reduced in patients with mild-to-moderate CKD and is associated with impaired VO 2 Peak. Assessment of VO 2 Peak by cardiopulmonary exercise testing can detect decrements in cardiovascular function during early stages of kidney function decline that may not be captured using resting left ventricular geometric indices alone. Background: Traditional diagnostic tools that assess resting cardiac function and structure fail to accurately reflect cardiovascular alterations in patients with CKD. This study sought to determine whether multidimensional exercise response patterns related to cardiovascular functional capacity can detect abnormalities in mild-to-moderate CKD. Methods: In a cross-sectional study, we examined 3075 participants from the Framingham Heart Study (FHS) and 451 participants from the Massachusetts General Hospital Exercise Study (MGH-ExS) who underwent cardiopulmonary exercise testing. Participants were stratified by eGFR: eGFR ≥90, eGFR 60–89, and eGFR 30–59. Our primary outcomes of interest were peak oxygen uptake (VO 2 Peak), VO 2 at anaerobic threshold (VO 2 AT), and ratio of minute ventilation to carbon dioxide production (VE/VCO 2 ). Multiple linear regression models were fitted to evaluate the associations between eGFR group and each outcome variable adjusted for covariates. Results: In the FHS cohort, 1712 participants (56%) had an eGFR ≥90 ml/min per 1.73 m 2 , 1271 (41%) had an eGFR of 60–89 ml/min per 1.73 m 2 , and 92 (3%) had an eGFR of 30–59 ml/min per 1.73 m 2 . In the MGH-ExS cohort, 247 participants (55%) had an eGFR ≥90 ml/min per 1.73 m 2 , 154 (34%) had an eGFR of 60–89 ml/min per 1.73 m 2 , and 50 (11%) had an eGFR of 30–59 ml/min per 1.73 m 2 . In FHS, VO 2 Peak and VO 2 AT were incrementally impaired with declining kidney function ( P < 0.001); however, this pattern was attenuated after adjustment for age. Percent-predicted VO 2 Peak at AT was higher in the lower eGFR groups ( P < 0.001). In MGH-ExS, VO 2 Peak and VO 2 AT were incrementally impaired with declining kidney function in unadjusted and adjusted models ( P < 0.05). VO 2 Peak was associated with eGFR ( P < 0.05) in all models even after adjusting for age. On further mechanistic analysis, we directly measured cardiac output (CO) at peak exercise by right heart catheterization and found impaired CO in the lower eGFR groups ( P ≤ 0.007). Conclusions: Cardiopulmonary exercise testing–derived indices may detect impairment in cardiovascular functional capacity and track CO declines in mild-to-moderate CKD.